Afuco™ Anti-HBV ADCC Therapeutic Antibody (Tuvirumab), ADCC Enhanced

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human monoclonal antibody expressed in CHO binding to human Hepatitis B virus. Tuvirumab is a human monoclonal antibody for the treatment of patients with chronic hepatitis B.
Supplier Creative Biolabs
Product # AFC-TAB-879
Pricing Inquiry
Host Human
Target HBV
Species Reactivity HBV
Type ADCC enhanced antibody
Applications ELISA, FC, IP, FuncS, IF, Neut
Storage Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback